TD Asset Management’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

TD Asset Management’s Portfolio TARO Stock Details TARO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-3,300	Closed	-$372K	–	1360
2017 Q3	$372K	Hold	3,300	–	–	﹤0.01%	1205
2017 Q2	$370K	Sell	3,300 -800	-20%	-$90.4K	﹤0.01%	1234
2017 Q1	$478K	Buy	4,100 +200	+5%	+$22.1K	﹤0.01%	1225
2016 Q4	$411K	Sell	3,900 -200	-5%	-$20.9K	﹤0.01%	1232
2016 Q3	$453K	Buy	4,100 +300	+8%	+$39.7K	﹤0.01%	1209
2016 Q2	$553K	Hold	3,800	–	–	﹤0.01%	1086
2016 Q1	$544K	Hold	3,800	–	–	﹤0.01%	1084
2015 Q4	$587K	Buy	+3,800	New	+$555K	﹤0.01%	1069

Other funds holding TARO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AJO LP Philadelphia, Pennsylvania $199M AUM 109.68% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Fort LP Chevy Chase, Maryland $39.6M AUM 37.11% 1-Year Est. Return

TD Asset Management's TARO Position: Q4 2017 in Review

TD Asset Management sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q4 2017, closing a stake of 3,300 shares — an estimated $372K sold.

TD Asset Management first reported a position in TARO in Q4 2015 and held it in 8 quarters. The position peaked at $587K in Q4 2015. 127 funds tracked by Wall St. Rank hold TARO as of Q4 2017.

TD Asset Management reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q4 2017 after selling out during the quarter.
TD Asset Management sold 3,300 Taro Pharmaceutical Industries Ltd. shares in Q4 2017, an estimated $372K.
TD Asset Management first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 8 quarters.
TD Asset Management's Taro Pharmaceutical Industries Ltd. position peaked at $587K in Q4 2015.
127 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q4 2017.

Based on TD Asset Management's 13F filing for Q4 2017, filed 2 Feb 2018.